AngioDynamics Shares Outstanding 2006-2019 | ANGO

AngioDynamics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
AngioDynamics Annual Shares Outstanding
(Millions of Shares)
2019 38
2018 38
2017 37
2016 36
2015 36
2014 35
2013 35
2012 25
2011 25
2010 25
2009 25
2008 24
2007 18
2006 13
2005 12
AngioDynamics Quarterly Shares Outstanding
(Millions of Shares)
Q4 2019 38
Q3 2019 38
Q2 2018 38
Q1 2018 37
Q4 2018 38
Q3 2018 37
Q2 2017 37
Q1 2017 37
Q4 2017 37
Q3 2017 37
Q2 2016 37
Q1 2016 37
Q4 2016 36
Q3 2016 36
Q2 2015 36
Q1 2015 36
Q4 2015 36
Q3 2015 36
Q2 2014 36
Q1 2014 36
Q4 2014 35
Q3 2014 36
Q2 2013 35
Q1 2013 35
Q4 2013 35
Q3 2013 35
Q2 2012 35
Q1 2012 35
Q4 2012 25
Q3 2012 25
Q2 2011 25
Q1 2011 25
Q4 2011 25
Q3 2011 25
Q2 2010 25
Q1 2010 25
Q4 2010 25
Q3 2010 25
Q2 2009 25
Q1 2009 25
Q4 2009 25
Q3 2009 24
Q2 2008 25
Q1 2008 24
Q4 2008 24
Q3 2008 24
Q2 2007 24
Q1 2007 24
Q4 2007 18
Q3 2007 19
Q2 2006 16
Q1 2006 19
Q4 2006 13
Q3 2006 13
Q2 2005 13
Q1 2005 13
Q4 2005 12
Q3 2005 12
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.796B $0.359B
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.479B 25.04
Intuitive Surgical (ISRG) United States $59.521B 54.85
Edwards Lifesciences (EW) United States $39.100B 39.07
IDEXX Laboratories (IDXX) United States $24.408B 64.03
Fresenius Medical Care AG KGaA (FMS) Germany $24.241B 15.93
Teleflex (TFX) United States $15.301B 33.15
Olympus (OCPNY) Japan $15.078B 112.82
SONOVA HOLDING (SONVY) Switzerland $14.501B 0.00
Sysmex ADR (SSMXY) Japan $14.145B 38.13
DexCom (DXCM) United States $13.644B 267.59
Hologic (HOLX) United States $12.620B 20.29
STERIS (STE) Ireland $12.544B 30.34
Varian Medical Systems (VAR) United States $12.269B 31.30
ABIOMED (ABMD) United States $11.491B 69.90
Masimo (MASI) United States $8.109B 49.69
Penumbra (PEN) United States $5.895B 249.54
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.555B 21.40
Globus Medical (GMED) United States $4.118B 25.68
Tandem Diabetes Care (TNDM) United States $3.627B 0.00
LivaNova (LIVN) United Kingdom $3.564B 23.23
Wright Medical Group (WMGI) Netherlands $3.321B 658.25
Cantel Medical (CMD) United States $3.301B 33.49
Glaukos (GKOS) United States $2.752B 0.00
Integer Holdings (ITGR) United States $2.651B 19.54
Nihon Kohden (NHNKY) Japan $2.366B 23.80
AVANOS MEDICAL, INC (AVNS) United States $1.989B 31.47
Nevro (NVRO) United States $1.941B 0.00
Inogen (INGN) United States $1.360B 30.11
OPKO Health (OPK) United States $1.293B 0.00
Silk Road Medical (SILK) United States $1.252B 0.00
Veracyte (VCYT) United States $1.187B 0.00
CryoLife (CRY) United States $1.093B 108.41
Tactile Systems Technology (TCMD) United States $1.043B 153.92
Accelerate Diagnostics (AXDX) United States $1.041B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.966B 27.98
Mesa Laboratories (MLAB) United States $0.914B 42.99
Pacific Biosciences Of California (PACB) United States $0.901B 0.00
Luminex (LMNX) United States $0.894B 116.94
ViewRay (VRAY) United States $0.887B 0.00
Natus Medical (BABY) United States $0.887B 20.53
AxoGen (AXGN) United States $0.764B 0.00
Fluidigm (FLDM) United States $0.752B 0.00
Quotient (QTNT) Switzerland $0.693B 0.00
Intersect ENT (XENT) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.559B 0.00
Corindus Vascular Robotics (CVRS) United States $0.544B 0.00
Si-Bone (SIBN) United States $0.488B 0.00
GenMark Diagnostics (GNMK) United States $0.356B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.351B 18.81
Accuray (ARAY) United States $0.317B 0.00
RTI Surgical (RTIX) United States $0.312B 38.36
TransEnterix (TRXC) United States $0.306B 0.00
Semler Scientific (SMLR) United States $0.291B 57.78
SeaSpine Holdings (SPNE) United States $0.239B 0.00
Neuronetics (STIM) United States $0.231B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
IRadimed (IRMD) United States $0.202B 38.53
Alphatec Holdings (ATEC) United States $0.201B 0.00
CRH Medical (CRHM) Canada $0.199B 69.00
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
Ekso Bionics Holdings (EKSO) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.083B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
T2 Biosystems (TTOO) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00